See analyst estimates and all valuation multiples for Pharmacies
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $172B | 0.4x | 10.3x | |
| $25.6B | 7.0x | 29.2x | |
| $23.6B | n/a | n/a | |
| $19.3B | 1.9x | 30.8x | |
| $11.7B | 0.3x | 5.0x | |
| $10.6B | 2.2x | 33.8x | |
| $9.3B | 1.1x | 13.7x | |
| $9.3B | 0.7x | 15.2x | |
| $7.2B | 0.8x | 13.0x | |
| $6.0B | 0.9x | 8.8x | |
| $4.9B | 1.7x | 11.9x | |
| $4.2B | 0.7x | 9.5x | |
| $4.1B | 0.5x | 10.4x | |
| $3.8B | 0.6x | 9.3x | |
| $3.8B | n/a | n/a | |
| $3.5B | 1.3x | 7.8x | |
| $3.4B | 1.0x | 8.1x | |
| $3.2B | 0.9x | 13.0x | |
| $3.0B | n/a | n/a | |
| $2.9B | 0.7x | 6.7x | |
| $2.8B | 0.4x | 4.8x | |
| $2.3B | 1.9x | 15.9x | |
| $2.2B | 0.8x | 10.6x | |
| $2.1B | n/a | n/a | |
| $2.1B | n/a | n/a | |
| $1.7B | n/a | n/a | |
| $1.7B | 0.5x | 22.7x | |
| $1.7B | 0.5x | 22.7x | |
| $1.5B | 0.4x | 5.5x | |
| $1.4B | 0.5x | 8.7x | |
| $1.3B | n/a | n/a | |
| $1.3B | n/a | n/a | |
| $1.2B | 1.5x | 4.5x | |
| $1.2B | 0.4x | n/a | |
| $1.2B | 1.6x | 18.6x | |
| $1.1B | 0.4x | 9.3x | |
| $1.0B | 0.8x | 9.7x | |
| $981M | 0.2x | 7.9x | |
| $965M | n/a | n/a | |
| $741M | n/a | n/a | |
| $666M | n/a | n/a | |
| $572M | 1.0x | n/a | |
| $526M | 0.5x | 7.5x | |
| $474M | 0.3x | -8.1x | |
| $379M | n/a | n/a | |
| $330M | n/a | n/a | |
| $326M | n/a | n/a | |
| $271M | 0.1x | n/a | |
| $245M | 0.6x | 8.5x | |
| $228M | n/a | n/a | |
| $143M | n/a | n/a | |
| $123M | n/a | n/a | |
| $85.1M | n/a | n/a | |
| $80.3M | n/a | n/a | |
| $55.7M | n/a | n/a | |
| $30.0M | 0.5x | -102.7x | |
| $24.6M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharmacies